Intellectual Property India Publishes Patent Application for Ras Inhibitors And Methods Of Use Thereof

MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202614004059 A) filed by Kestrel Therapeutics Inc. on January 15, 2026, for Ras Inhibitors And Methods Of Use Thereof.

Inventors include Ahmad, Omar K.; Lajkiewicz, Neil; Fernando, Dilinie P.; Rui, Huan; and Zhang, Yun.

The application for the patent was published on July 31, 2026, under issue no. 31/2026.

Abstract: RAS INHIBITORS AND METHODS OF USE THEREOF The disclosure provides compounds, e.g., compounds of Formulae I through IX, and subformulae thereof, and their use in treating medical diseases or disorders, such as cancer. Pharmaceutical compositions and methods of making compounds of the disclosure are provided. The compounds are contemplated to be modulators of Ras (e.g., K-Ras).

Disclaimer: Curated by HT Syndication.